The ESWI News Bulletin offers you a selection of influenza-related articles collected from a range of media sources. It does not represent the opinions of ESWI or its members.
Kindly e-mail any comments or questions regarding the ESWI News Bulletin to email@example.com
New analysis of efficacy data confirms that timely administration of the antiviral influenza drug Tamiflu considerably reduces the impact of an influenza infection in adults. The study results have now been published in The Lancet.
‘People with diabetes benefit from flu vaccination’
Anne Felton, President of the Foundation of European Nurses in Diabetes (FEND) says people with diabetes can benefit from vaccination against flu and other infectious diseases.
Council of the European Union conclusions on vaccination
On 1 December 2014, the Council of the European Union adopted conclusions on vaccinations as an effective tool in public health. The Conclusions recognize that an evidence-based, cost-effective, safe and efficient immunization system is an integral part of a well-functioning health system.
Eurosurveillance Rapid Communication
Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype